Accuracy of MSSA Nasal Swab Testing
Nasal swabs for detecting methicillin-sensitive Staphylococcus aureus (MSSA) have limited direct evidence, but extrapolating from MRSA screening data and general S. aureus detection studies, they demonstrate high specificity (>95%) and excellent negative predictive value (>99%), though sensitivity is moderate (approximately 50-80%).
Key Performance Characteristics
Sensitivity and Specificity
- Nasal swabs for S. aureus detection show sensitivity of 84-98% depending on culture media used, with CHROMagar Staph aureus demonstrating superior sensitivity (98%) compared to traditional mannitol salt agar (84.3%) 1
- For MRSA specifically, nasal screening demonstrates sensitivity of 40.3% (95% CI 17.4-68.4) and specificity of 93.7% (95% CI 77.1-98.4) for predicting ventilator-associated pneumonia 2
- In cancer patients, MRSA nasal swabs showed overall sensitivity of 50.9% and specificity of 98.4% 3
Negative Predictive Value (Most Clinically Relevant)
- The negative predictive value for MRSA nasal swabs is consistently >99% across multiple studies and patient populations 3
- In critically ill children with severe pneumonia, rapid MRSA nasal PCR demonstrated NPV >99% 4
- For bloodstream infections specifically, NPV reaches 99.8% 3
- For respiratory infections, NPV is 98.5% 3
Clinical Context and Limitations
Population Prevalence Matters
- 15-30% of the general population are nasal carriers of MSSA, with 20-40% carrying any S. aureus (MSSA or MRSA combined) 5
- Approximately 5% of the general population carry MRSA, though this rises to 5-15% in ICU patients 5
Sampling Technique Critically Affects Accuracy
- Undirected nasal/nasopharyngeal swabs show poor correlation with endoscopically-directed middle meatal swabs due to contamination from the nasal vestibule 6
- Endoscopically-directed middle meatal (EDMM) swabs demonstrate 73.8-93% concordance with maxillary sinus aspirates, making them the preferred technique when assessing sinus infections 6
- Simple anterior nares swabs remain the standard for colonization screening but may miss deeper colonization 6
Practical Clinical Application
When to Trust a Negative Result
- A negative MSSA/MRSA nasal swab effectively rules out staphylococcal infection in most clinical scenarios, particularly for bloodstream and respiratory infections 4, 3
- In ICUs with S. aureus prevalence below 30%, a negative Gram stain (analogous principle) reduces post-test probability from 15% pre-test to approximately 6% 2
- This high NPV supports de-escalation or withholding of empiric anti-staphylococcal antibiotics when the nasal swab is negative 2
When to Be Cautious About a Positive Result
- Positive predictive value is lower and varies by clinical context, as colonization does not equal active infection 3
- Individuals colonized with MSSA have 3-6 fold increased risk of developing MSSA surgical site infections, making positive results clinically relevant for pre-operative risk stratification 5
- Prior antibiotic exposure (present in 82% of cancer patients in one study) may reduce sensitivity 3
Common Pitfalls to Avoid
- Do not use undirected nasal swabs when evaluating sinus infections—they have poor correlation with actual sinus pathogens due to contamination 6
- Do not assume a positive colonization swab means active infection—it indicates increased risk but requires clinical correlation 5
- Do not ignore the timing—swabs taken >7 days from clinical cultures show reduced correlation 3
- Recognize that 25-99% of microbial communities may be nonculturable with standard techniques, potentially missing difficult-to-culture organisms 6